Literature DB >> 31115515

The protective effect of the TUG1/miR‑197/MAPK1 axis on lipopolysaccharide‑induced podocyte injury.

Dong Zhao1, Zheng Liu2, Heng Zhang3.   

Abstract

The podocyte, a type of glomerular epithelial cell, is the key constituent of the filtration barrier layer in the kidney. Previous studies have shown that long non‑coding RNA (lncRNA)‑taurine‑upregulated gene 1 (TUG1) served a protective role in diabetes‑induced podocyte damage. The aim of the present study was to investigate the potential role of TUG1 in the progress of podocyte injury induced by lipopolysaccharide (LPS), and explore the underlying mechanisms. The results showed that TUG1 expression was suppressed in LPS‑induced podocytes. Enhanced TUG1 expression by exogenous recombinant vector regulated the expression of podocyte associated proteins [Nephrin, Podocin and CCAAT/enhancer‑binding protein (CHOP)]. A marked decrease was observed in the level the albumin influx in cells transfected with TUG1. Further study indicated that microRNA (miR)‑197 is a potential target of TUG1. The enhanced level of miR‑197 induced by LPS was inhibited in cells transfected with TUG1. The decreased Nephrin and Podocin expression, upregulated CHOP expression and the increased albumin influx were slightly enhanced by miR‑197 mimic transfection, while markedly suppressed by miR‑197 inhibitor transfection in LPS‑induced podocytes. Mitogen‑activated protein kinase (MAPK) protein was predicted as a potential target of miR‑197. The downregulated expression of phosphorylated‑MAPK/MAPK induced by LPS was significantly suppressed by TUG1 transfection in podocytes. In addition to this, autophagy was promoted by TUG1 transfection via the elevation of the Beclin1 and light chain (LC)3 II/LC3 I levels, and suppressing p62 expression. However, the p38 MAPK inhibitor SB203580 reversed the changes that TUG1 induced in the levels of Beclin1, LC3 II/LC3 I and p62. Taken together, these results demonstrated that LPS‑induced podocyte injury could be alleviated by the TUG1/miR‑197/MAPK1 axis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31115515     DOI: 10.3892/mmr.2019.10216

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus.

Authors:  Xiao-Yan Cui; Xiao Wu; Dan Lu; Dan Wang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

Review 2.  Autophagy Function and Regulation in Kidney Disease.

Authors:  Gur P Kaushal; Kiran Chandrashekar; Luis A Juncos; Sudhir V Shah
Journal:  Biomolecules       Date:  2020-01-07

Review 3.  Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis.

Authors:  Yue-Yu Gu; Jing-Yun Dou; Xiao-Ru Huang; Xu-Sheng Liu; Hui-Yao Lan
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

4.  Ginsenoside Rg3 alleviates septic liver injury by regulating the lncRNA TUG1/miR-200c-3p/SIRT1 axis.

Authors:  Pan Wu; Xiao Yu; Yue Peng; Qian-Lu Wang; Long-Tian Deng; Wei Xing
Journal:  J Inflamm (Lond)       Date:  2021-12-20       Impact factor: 4.981

5.  LncRNA KCNQ1OT1 (potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1) aggravates acute kidney injury by activating p38/NF-κB pathway via miR-212-3p/MAPK1 (mitogen-activated protein kinase 1) axis in sepsis.

Authors:  Haixia Wang; Hongbin Mou; Xiaolan Xu; Changhua Liu; Gang Zhou; Bo Gao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Network Pharmacology Combined with Bioinformatics to Investigate the Mechanisms and Molecular Targets of Astragalus Radix-Panax notoginseng Herb Pair on Treating Diabetic Nephropathy.

Authors:  Jie Zhao; Chao Mo; Wei Shi; LiFeng Meng; Jun Ai
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-24       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.